Form 4: Medpace Holdings Director Ashley M. Keating Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Director Ashley M. Keating exercised stock options and sold shares of Medpace Holdings, Inc. on March 7, 2024.
Summary
- On March 7, 2024, Ashley M. Keating, a director of Medpace Holdings, Inc., exercised stock options to acquire 472 shares of common stock at a price of $54.99 per share.
- Simultaneously, Keating sold 472 shares of common stock at a price of $415.
- The transactions were executed pursuant to a limit order placed by Keating during an open window period.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of insider trading activity, neither particularly positive nor negative.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company directors. It's a standard practice for publicly traded companies and their executives.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/14/2020 | The stock option vested in full. |
| 05/17/2026 | Expiration date of the stock options. |
| 03/07/2024 | Date of the stock option exercise and sale of shares. |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.